ReviewBiomarker research2024

Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma.

Nan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.